Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming "collateral effect".

Autor: Cataldo MA; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy. Electronic address: adriana.cataldo@inmi.it., Tetaj N; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy., Selleri M; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy., Marchioni L; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy., Capone A; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy., Caraffa E; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy., Caro AD; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy., Petrosillo N; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
Jazyk: angličtina
Zdroj: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2020 Dec; Vol. 23, pp. 290-291. Date of Electronic Publication: 2020 Oct 29.
DOI: 10.1016/j.jgar.2020.10.004
Databáze: MEDLINE